ABCL: AbCellera Biologics Inc Company Short-Term Debt
AbCellera Biologics (ABCL) production capacities rely on state-of-the-art AI clusters and laboratories with minimal depreciation. Business profitability is based on partner payments for platform access and future sales royalties. The stock's price history, where the indicator stands at 0.00, confirms the company's significant pricing power due to its unique express antibody discovery method and the inelastic demand for innovative medicines.
Metric breakdowns and analytics for AbCellera (ABCL)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital AbCellera Biologics|ABCL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity AbCellera Biologics Inc.|ABCL - Company Total Debt|Debt to Book Capitalization Ratio AbCellera Biologics Inc.|ABCL - Company Long-Term Liabilities|Company Current Liabilities AbCellera|Quick Liquidity abcellera.com
- net income and valuation multiples indicators:
Initial company analysis:ABCL - AbCellera Corp
AbCellera Biologics (ABCL) monetizes its IT platform through partnerships with pharma behemoths, minimizing its own R&D expenditures. The trend in short-term debt with maturities of up to one year reflects the current pressure on the business's liquidity. This metric captures the market consensus on obligations due for repayment within twelve months. Analyzing the debt amortization trajectory allows for the timely detection of cash gap risks. This confirms the financial stability of the company's diversified model.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM - Company Short-Term Debts|GOSS: Company Short-Term Debts|KALV (kalvista.com) - Company Short-Term Debt|SEPN (Septerna) - Company Short-Term Debts|Company Current Liabilities Pieris Pharma (PVLA)|Company Short-Term Debts SVRA|RIGL - Short-Term Debt|Company Short-Term Debt AnaptysBio, Inc. ANAB|astriatx.com - Company Short-Term Debt|ENGN - Company Short-Term Debt|RAPT: Company Short-Term Debt|JBIO: Company Short-Term Debts|Short-Term Debt Aclaris Therapeutics, Inc (ACRS)|Company Short-Term Debt Kyverna Therapeutics|TLSA: Company Short-Term Loans and Borrowings|Company Short-Term Debts CABA|Company Short-Term Debts Ventyx Biosciences Inc. (VTYX)|Theratechnologies Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Short-Term Debts|AGEN: Company Short-Term Debt|CLYM: Company Short-Term Debts|ZURA - Short-Term Debt Volume|Company Short-Term Debt aTyr|Short-Term Debt Adagene Corp ADAG|Company Short-Term Debt ImageneBio Inc (IMA)|Company Short-Term Debt STTK (shattucklabs.com)|Company Short-Term Debt Equillium EQ|Connect Biopharma Holdings (CNTB) - Short-Term Debt|Immunic Inc - Company Short-Term Debts|Short-Term Indebtedness Atara Biotherapeutics (ATRA)|IFRX: Company Short-Term Debts|XFOR - Short-Term Debt Volume|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Current Liabilities Celularity Corp (CELU)|Company Short-Term Debt INmune Bio Corp (INMB)|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Company Short-Term Debts|ENLV: Company Short-Term Debt|QTTB: Company Short-Term Debts|Company Current Liabilities GeoVax Corp|Company Short-Term Debt Edesa Biotech, Inc.|Company Short-Term Debt IBIO|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)